PLOS
open access
CC BY 4.0
Epistasis and pleiotropy constrain the evolution of cross-reactive breadth in a broadly neutralizing influenza antibody
The highly conserved influenza virus hemagglutinin (HA) stem domain is a major target for broadly neutralizing antibodies (bnAbs). However, despite being discovered more than a decade ago, the IGHV1-69-encoded CR9114 remains the only HA stem bnAb that cross-reacts with both influenza A and B viruse
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors#180214
- Data Sheet 12_Multi-omics integration reveals vaccine-specific molecular signatures and temporal dynamics of COVID-19 immune responses.csv#1157842
- SNX-BAR proteins 5 and 6 are required for NCOA7-AS antiviral activity against influenza A virus#1079392
- Global comparison of influenza A and B epidemiology identifies consistent geographic and socio-demographic predictors#10179
- Anti-inflammatory Effects of Macrolide Treatment in Influenza Lower Respiratory Tract Infections#848309
Record · ID 1121214
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive